Wnt/?-catenin regulates blood pressure and kidney injury in rats.
Ontology highlight
ABSTRACT: Activation of the renin-angiotensin system (RAS) plays a pivotal role in mediating hypertension, chronic kidney and cardiovascular diseases. As Wnt/?-catenin regulates multiple RAS genes, we speculated that this developmental signaling pathway might also participate in blood pressure (BP) regulation. To test this, we utilized two rat models of experimental hypertension: chronic angiotensin II infusion and remnant kidney after 5/6 nephrectomy. Inhibition of Wnt/?-catenin by ICG-001 blunted angiotensin II-induced hypertension. Interestingly, angiotensin II was able to induce the expression of multiple Wnt genes in vivo and in vitro, thereby creating a vicious cycle between Wnt/?-catenin and RAS activation. In the remnant kidney model, renal ?-catenin was upregulated, and delayed administration of ICG-001 also blunted BP elevation and abolished the induction of angiotensinogen, renin, angiotensin-converting enzyme and angiotensin II type 1 receptor. ICG-001 also reduced albuminuria, serum creatinine and blood urea nitrogen, and inhibited renal expression of fibronectin, collagen I and plasminogen activator inhibitor-1, and suppressed the infiltration of CD3+ T cells and CD68+ monocytes/macrophages. In vitro, incubation with losartan prevented Wnt/?-catenin-mediated fibronectin, ?-smooth muscle actin and Snail1 expression, suggesting that the fibrogenic action of Wnt/?-catenin is dependent on RAS activation. Taken together, these results suggest an intrinsic linkage of Wnt/?-catenin signaling with BP regulation. Our studies also demonstrate that hyperactive Wnt/?-catenin can drive hypertension and kidney damage via RAS activation.
SUBMITTER: Xiao L
PROVIDER: S-EPMC6502648 | biostudies-literature | 2019 Jun
REPOSITORIES: biostudies-literature
ACCESS DATA